Fetal Cell Receptors Repertoire

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 6, 2024

Primary Completion Date

July 1, 2026

Study Completion Date

February 1, 2027

Conditions
Venous UlcerSickle Cell UlcerDiabetic UlcerPost-partum WomenMixed Ulcer
Interventions
OTHER

Saliva sampling

HLA genotyping. The technique should allow to identify, for children's, a paternal HLA antigen not shared with the mothers.

OTHER

Blood sampling

"Maternal Blood samples will be incubated with the appropriate antibody, targeting the microchimeric fetal cells of each patient, as well as with a cell viability marker (DAPI). The samples were then be processed through the BD FACS Aria III to sort the fetal cells,~The following steps - RNA extraction, quality control, retrotranscription, preparation of the library, sequencing and transcriptomic analysis - will be carried out according to the Smart-seq3 protocol. The data will be sent for in-depth analysis and confirmation of the results. Additional functional experiments may also be carried out."

OTHER

Interviews

V2 and/or V3

OTHER

Clinical examination

V2 and/or V3

Trial Locations (1)

75014

RECRUITING

Dermatology unit - Cochin Hospital - APHP, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06031714 - Fetal Cell Receptors Repertoire | Biotech Hunter | Biotech Hunter